title: Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations.
authors.affiliation: Department of Medicine, Surgery and Neuroscience, University of Siena, 53100, Siena, Italy, laraditorom@libero.it.
authors.forename: L
authors.initials: L
authors.lastname: Di Toro Mammarella
authors.forename: A
authors.initials: A
authors.lastname: Mignarri
authors.forename: C
authors.initials: C
authors.lastname: Battisti
authors.forename: L
authors.initials: L
authors.lastname: Monti
authors.forename: V
authors.initials: V
authors.lastname: Bonifati
authors.forename: F
authors.initials: F
authors.lastname: Rasi
authors.forename: A
authors.initials: A
authors.lastname: Federico
mesh_terms: D027682:Cation Transport Proteins / Q000235:genetics*; D015913:Chelation Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008659:Metabolic Diseases / Q000150:complications / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D020734:Parkinsonian Disorders / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D000075703:Zinc Transporter 8
chemical_list: D027682:Cation Transport Proteins; C492522:SLC30A8 protein, human; D000075703:Zinc Transporter 8